←Back to Expert Scholars
Translational Medicine / 转化医学Allogeneic HCT, Clinical Trials
Miguel-Angel Perales
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Chief, Adult Bone Marrow Transplant Service
90
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Miguel-Angel Perales chairs adult HCT at MSKCC and co-led BMT CTN 1703 establishing PTCy as superior GVHD prophylaxis. His research compares HCT with CAR-T in lymphoma and myeloma. He is ASTCT past president.
Share:
🧪Research Fields 研究领域
allogeneic HCT
CAR-T vs HCT
lymphoma transplant
PTCy GVHD prevention
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Miguel-Angel Perales 的研究动态
Follow Miguel-Angel Perales's research updates
留下邮箱，当我们发布与 Miguel-Angel Perales（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment